Document Detail


ICP monitoring: complications and associated factors.
MedLine Citation:
PMID:  975699     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
1. Patients with complications when compared with those not developing a complication: a. Were older, 44.4 vs. 34.5 years; b. Were monitored longer, 14.0 vs. 6.5 days; c. Were treated with steroids longer, 18.3 vs. 10.3 days; d. Were hospitalized longer, 35.7 vs. 27.7 days; e. Are twice as likely to die; f. Average age of those dying is older, 46 vs. 30 years; g. Have no clear relationship to antibiotics; h. Do not have a preponderance of single diagnostic category to account for these differences; i. Complications were always controlled with standard therapy; j. An ICP complication was almost never responsible, per se, for death. 2. Over all complication rate was 18%; due to monitoring was 4.5 to 11.5%. 3. Monitoring was responsible for, or contributed to, 25 to 60% of the complications. 4. No complications occurred when monitoring was discontinued within 3 days. 5. Long periods of treatment with steroids increased the risk of a complication developing. 6. Long periods of monitoring were associated with an increased risk of complication. 7. "Individual" factors are partly responsible for the development of a complication, and death. 8. There are two groups of complications: "early" and "late." A. Those most likely to be monitor related occur "late" and account for 35% of the complications. B. Those developing "early" infection account for 65% of the complications and are most likely caused by factors other than monitoring. While there are complications directly attributable to monitoring, the rate is low and they are readily controlled by standard neurosurgical management. While monitoring may increase the morbidity, it does not increase the mortality. We feel that the over-all risk is small and that the returns are great--both in terms of knowledge and patient benefit.
Authors:
M J Rosner; D P Becker
Related Documents :
23738949 - Impact of gait analysis on correction of excessive hip internal rotation in ambulatory ...
1247399 - Steroid therapy in acute cerebral infarction.
17004259 - 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo ...
17175369 - Effect of plasmapheresis for acute humoral rejection after heart transplantation.
19151659 - Mycophenolate mofetil (mmf) following penetrating high-risk keratoplasty: long-term res...
16364859 - Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial ...
17243069 - Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidi...
25179189 - Persistence in treatment for one year among patients in nigeria with first-episode schi...
23615379 - Thrombolytics in acute ischaemic stroke: historical perspective and future opportunities.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical neurosurgery     Volume:  23     ISSN:  0069-4827     ISO Abbreviation:  Clin Neurosurg     Publication Date:  1976  
Date Detail:
Created Date:  1976-12-23     Completed Date:  1976-12-23     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  2985141R     Medline TA:  Clin Neurosurg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  494-519     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Age Factors
Anti-Bacterial Agents / therapeutic use
Brain Diseases / mortality
Brain Injuries / mortality
Catheterization / adverse effects
Craniotomy / adverse effects
Humans
Infection / etiology
Intracranial Pressure*
Meningitis / etiology
Monitoring, Physiologic* / adverse effects
Postoperative Complications
Steroids / therapeutic use
Time Factors
Chemical
Reg. No./Substance:
0/Anti-Bacterial Agents; 0/Steroids

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Complications of surgery for subdural hematoma.
Next Document:  Radical surgical treatment of craniopharyngioma.